Delivery Order SPE2DE24D0021-SPE2D625F9TM5
- Not listed
- This federal contract award is for the delivery of Reagent Toxicology CEDIA Buprenorphine 1 to the U.S. government. The $7,489.00 contract was awarded to Fisher Scientific Company L.L.C., a for-profit limited liability company that is a major supplier of scientific products, equipment, and services to federal agencies. The contract, which is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, has an ultimate completion date of July 1, 2025. Fisher Scientific has been...
- This federal contract award was made by the Medical Supply Chain, a Defense agency, to Fisher Scientific Company L.L.C., a for-profit limited liability company, for the delivery of reagents for toxicology testing using the CEDIA buprenorphine assay. The fixed-price contract with economic price adjustment has a ceiling value of $6,469.00 and a completion date of June 25, 2025. No set-aside designation was used. This award appears to be a delivery order under a larger federal contract vehicle,...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 31, 2025, for the procurement of reagent toxicology methadone metabolite supplies, valued at $1,177.60, with an ultimate completion date of August 7, 2025. This fixed-price delivery order with economic price adjustment represents a child contract under a larger federal vehicle and will be performed in Pittsburgh, PA. The award was made by the Medical Supply Chain division of the Department of Defense without a set-aside...
- This is a federal contract award for a delivery order to Fisher Scientific Company L.L.C., doing business as Fisher Scientific, a for-profit limited liability company and major supplier of scientific products, equipment, and services to federal government agencies. The contract, valued at $6,469.00, is for the provision of REAGENT TOXICOLOGY CEDIA BUPRENORPHINE 1. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of June 12, 2025. It was...
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $8,266.56 for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, on July 24, 2025. The contract carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by July 31, 2025. This is an uncompensated delivery order with no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 by the Defense Medical Supply Chain federal agency for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack. This fixed-price delivery order with economic price adjustment was awarded on July 18, 2025, with an ultimate completion date of July 25, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract, indicating it falls under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,001.86 on July 31, 2025, for CBT Advanced 0.5mL Standard supplies to support the Medical Supply Chain, a defense-focused federal agency. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is classified as a child contract and carries no set-aside designation, reflecting Fisher Scientific's competitive positioning in the federal marketplace. Performance will be completed...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,199.92 on July 21, 2025, for the procurement of Profile-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack (Contract Number 4568847894). The contract is fixed price with economic price adjustment provisions and carries an ultimate completion date of July 28, 2025. Performance will occur in Pittsburgh, Pennsylvania, and the award was made without a set-aside designation, indicating open competition. The funding federal...
- This is a delivery order awarded by the Medical Supply Chain division of the Department of Defense to Fisher Scientific Company L.L.C., a major supplier of scientific products, equipment, and services to federal agencies. The $1,495.68 fixed-price contract with economic price adjustment is for the delivery of 4567786123 CEDIA BUPRENORPHN CAL 5NG 5ML. This order is placed under Fisher Scientific's existing Multiple Award Schedule (MAS) contract, which enables the efficient procurement of...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F9TM5Delivery Order
Fisher Scientific Company L.L.C. received a delivery order award on July 31, 2025, from the Department of Defense's Medical Supply Chain for reagent toxicology CEDIA buprenorphine supplies, with a ceiling value of $8,323.12. This fixed-price delivery order with economic price adjustment provisions is structured as a child contract, indicating it derives from a larger parent agreement—specifically Fisher Scientific's Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans Integrated Service Network 1 (VISN 1), valued at $1.65M and running through September 30, 2030. The work will be performed in Pittsburgh, PA 15275. No set-aside designation was applied to this award, reflecting Fisher Scientific's competitive standing in federal procurement. The supplies being delivered support laboratory toxicology testing and drugs-of-abuse screening across federal healthcare facilities. Fisher Scientific, a major supplier of scientific products and laboratory equipment registered in SAM.gov since 2001, has an established track record providing specialized testing solutions and reagents to the Department of Veterans Affairs, National Institutes of Health, and other federal agencies. The CEDIA buprenorphine reagents procured under this delivery order will support ongoing substance abuse testing and monitoring initiatives at VISN 1 laboratories across the Northeastern United States, with completion expected by August 7, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/31/25 |